Method for administering an inhalable compound

ABSTRACT

A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is related to and claims the benefit of theearliest available effective filing date(s) from the following listedapplication(s) (the “Related Applications”) (e.g., claims earliestavailable priority dates for other than provisional patent applicationsor claims benefits under 35 USC § 119(e) for provisional patentapplications, for any and all parent, grandparent, great-grandparent,etc. applications of the Related Application(s)). All subject matter ofthe Related Applications and of any and all parent, grandparent,great-grandparent, etc. applications of the Related Applications isincorporated herein by reference to the extent such subject matter isnot inconsistent herewith.

RELATED APPLICATIONS

-   -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Dec. 30, 2008, application Ser. No. 12/317,934, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Dec. 31, 2008, application Ser. No. 12/319,143, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Feb. 12, 2009, application Ser. No. 12/378,284, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Feb. 13, 2009, application Ser. No. 12/378,485, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Feb. 20, 2009, application Ser. No. 12/380,013, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Feb. 23, 2009, application Ser. No. 12/380,108, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Feb. 27, 2009, application Ser. No. 12/380,587, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Mar. 2, 2009, application Ser. No. 12/380,679, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Mar. 25, 2009, application Ser. No. 12/383,509, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Mar. 26, 2009, application Ser. No. 12/383,819, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Mar. 31, 2009, application Ser. No. 12/384,104, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 1, 2009, application Ser. No. 12/384,203, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 20, 2009, application Ser. No. 12/386,574, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 21, 2009, application Ser. No. 12/386,669, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 27, 2009, application Ser. No. 12/387,057, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 28, 2009, application Ser. No. 12/387,151, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed Apr. 30, 2009, application Ser. No. 12/387,321, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of United        States patent application entitled METHODS AND SYSTEMS FOR        PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE;        ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A.        SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors,        filed May 1, 2009, application Ser. No. 12/387,472, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date.

The United States Patent Office (USPTO) has published a notice to theeffect that the USPTO's computer programs require that patent applicantsreference both a serial number and indicate whether an application is acontinuation or continuation-in-part. Stephen G. Kunin, Benefit ofPrior-Filed Application, USPTO Official Gazette Mar. 18, 2003, availableat http://www.uspto.gov/web/offices/com/sol/og/2003/week11/patbene.htm.The present Applicant Entity (hereinafter “Applicant”) has providedabove a specific reference to the application(s) from which priority isbeing claimed as recited by statute. Applicant understands that thestatute is unambiguous in its specific reference language and does notrequire either a serial number or any characterization, such as“continuation” or “continuation-in-part,” for claiming priority to U.S.patent applications. Notwithstanding the foregoing, Applicantunderstands that the USPTO's computer programs have certain data entryrequirements, and hence Applicant is designating the present applicationas a continuation-in-part of its parent applications as set forth above,but expressly points out that such designations are not to be construedin any way as any type of commentary and/or admission as to whether ornot the present application contains any new matter in addition to thematter of its parent application(s).

SUMMARY

In an aspect, a method includes, but is not limited to, dispensing adose of an inhalable compound according to a dosing instruction set; andmaintaining a hands-free article for dispensing an inhalable compound inan operable dispensing position. In addition to the foregoing, othermethod aspects are described in the claims, drawings, and text forming apart of the present disclosure.

In an aspect, a method includes, but is not limited to, dispensing adose of an inhalable compound according to a dosing instruction set;maintaining a hands-free article for dispensing an inhalable compound inan operable dispensing position; and receiving a dose of an inhalablecompound for dispensing. In addition to the foregoing, other methodaspects are described in the claims, drawings, and text forming a partof the present disclosure.

In an aspect, a method includes dispensing a dose of an inhalablecompound according to a dosing instruction set; maintaining a hands-freearticle for dispensing an inhalable compound in an operable dispensingposition; and receiving the inhalable compound. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

In an aspect, a method includes dispensing a dose of an inhalablecompound according to a dosing instruction set; maintaining a hands-freearticle for dispensing an inhalable compound in an operable dispensingposition; and supporting a hands-free aerosol delivery system on thebody of a mammal. In addition to the foregoing, other method aspects aredescribed in the claims, drawings, and text forming a part of thepresent disclosure.

In an aspect, a method includes detecting a medical condition parameterof a mammal according to a medical condition parameter request;maintaining a hands-free article for dispensing an inhalable compound inan operable dispensing position; and dispensing a dose of an inhalablecompound according to a dosing instruction set. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

In addition to the foregoing, various other method and/or system and/orprogram product aspects are set forth and described in the teachingssuch as text (e.g., claims and/or detailed description) and/or drawingsof the present disclosure.

The foregoing is a summary and thus may contain simplifications,generalizations, inclusions, and/or omissions of detail; consequently,those skilled in the art will appreciate that the summary isillustrative only and is NOT intended to be in any way limiting. Otheraspects, features, and advantages of the devices and/or processes and/orother subject matter described herein will become apparent in theteachings set forth herein.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1A is a front elevation view illustrating a collar for dispensingone or more inhalable compounds.

FIG. 1B is a top plan view of a collar for dispensing one or moreinhalable compounds.

FIG. 1C is a partial cross-sectional side elevation view of a collar fordispensing one or more inhalable compounds.

FIG. 1D is a partial cross-sectional side elevation view of a collar fordispensing one or more inhalable compounds.

FIG. 1E is a schematic of a collar for dispensing one or more inhalablecompounds.

FIG. 1F is a schematic of a compound for being dispensed by a collar fordispensing one or more inhalable compounds.

FIG. 1G is a schematic of a compound for being dispensed by a collar fordispensing one or more inhalable compounds.

FIG. 1H is a schematic of a collar for dispensing one or more inhalablecompounds, where the collar is connected to various storage media.

FIG. 2 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 3 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 4 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 5 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 6 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 7 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 8 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 9 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 10 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 11 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 12 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 13 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 14 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 15 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 16 illustrates an alternative embodiment of the operational flow ofFIG. 56.

FIG. 17 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 18 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 19 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 20 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 21 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 22 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 23 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 24 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 25 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 26 illustrates an alternative embodiment of the operational flow ofFIG. 57.

FIG. 27 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 28 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 29 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 30 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 31 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 32 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 33 illustrates an alternative embodiment of the operational flow ofFIG. 59.

FIG. 34 illustrates an alternative embodiment of the operational flow ofFIG. 60.

FIG. 35 illustrates an alternative embodiment of the operational flow ofFIG. 60.

FIG. 36 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 37 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 38 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 39 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 40 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 41 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 42 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 43 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 44 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 45 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 46 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 47 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 48 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 49 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 50 illustrates an alternative embodiment of the operational flow ofFIG. 49.

FIG. 51 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 52 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 53 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 54 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 55 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 56 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 57 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 58 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 59 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 60 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 61 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 62 illustrates an operational flow representing example operationsrelated to maintaining a hands-free article for dispensing an inhalablecompound according to a dosing instruction set, where the hands-freearticle is maintained in an operable dispensing position.

FIG. 63 illustrates an alternative embodiment of the operational flow ofFIG. 62.

FIG. 64 illustrates an alternative embodiment of the operational flow ofFIG. 62.

FIG. 65 illustrates an alternative embodiment of the operational flow ofFIG. 62.

FIG. 66 illustrates an alternative embodiment of the operational flow ofFIG. 62.

FIG. 67 illustrates an alternative embodiment of the operational flow ofFIG. 62.

FIG. 68 illustrates an alternative embodiment of the operational flow ofFIG. 62.

DETAILED DESCRIPTION

In the following detailed description, reference is made to theaccompanying drawings, which form a part hereof. In the drawings,similar symbols typically identify similar components, unless contextdictates otherwise. The illustrative embodiments described in thedetailed description, drawings, and claims are not meant to be limiting.Other embodiments may be utilized, and other changes may be made,without departing from the spirit or scope of the subject matterpresented here.

Referring generally to FIGS. 1A through 1H, a hands-free article fordispensing one or more inhalable compounds is described in accordancewith the present disclosure. The hands-free article, such as collar 100,may be worn by a subject 102 who can inhale a compound 104 dispensed bythe collar 100. Although the subject 102 is depicted as a human in theaccompanying figures, the subject can generally include any biologicalentity having respiratory organs (e.g., lungs), such as a mammalianentity (e.g., a human, a dog, a lion, or another mammal), an avianentity (e.g., a bird of prey or another avian), an amphibian entity(e.g., a frog or another amphibian), a reptilian entity (e.g., analligator, a crocodile, a tortoise, or another reptile), as well asother biological entities having respiratory organs.

The collar 100 is maintained in an operable dispensing position. Forexample, the collar 100 may comprise a support for a hands-free aerosoldelivery system on the body of a mammal. Thus, the collar 100 may bedisposed around a portion of the body of the subject 102. For example,in one embodiment, the collar 100 may encircle a neck portion 106 of thesubject 102. In an embodiment, the collar 100 may encircle a limbportion (e.g., wrist portion 108) of the subject 102. In an embodiment,the collar 100 may encircle a torso portion (e.g., chest portion 110) ofthe subject 102. In an embodiment, the collar 100 may encircle a headportion 112 of the subject 102. It should be noted that theabove-mentioned embodiments are provided by way of example and are notmeant to be limiting of the present disclosure. Thus, it is contemplatedthat the collar 100 may be maintained in an operable dispensing positionby attaching it to a variety of other portions of the body of thesubject 102.

The collar 100 may comprise a support member having a first end 114 anda second end 116. The first end 114 may be connected to the second end116, encircling and creating a closed loop (e.g., a circle) about thebody part of the subject 102. In an embodiment, the first end 114 may beconnected to the second end 116 via a magnet 118. In an embodiment, thefirst end 114 of the collar 100 may be connected to the second end 116of the collar 100 via a hook 120. In an embodiment, the first end 114may be connected to the second end 116 via a snap connection 122. In anembodiment, the first end 114 of the collar 100 may be connected to thesecond end 116 of the collar 100 via a threaded connection 124. In anembodiment, the first end 114 may be connected to the second end 116 viaa belt-like connection 126. It will be appreciated that this list ofconnections is provided by way of example and is not meant to berestrictive of the present disclosure. Other fastening devices may beutilized with the collar 100.

The collar 100 includes a dispensing module 128 for dispensing someamount of material, such as a dose (e.g., measured quantity, prescribedquantity, therapeutic quantity, etc.) of a compound 104 (e.g., organiccompound, pharmaceutical compound, therapeutic compound, homeopathiccompound, nutraceutical compound, biological material, protein, nucleicacid, cell, peptide, etc.) for modulating, curing, diagnosing,mitigating, preventing, or treating one or more of a disease, disorder,symptom or a condition. Additionally, the compound 104 may be utilizedfor enhancing one or more of a physical well-being or a mentalwell-being. The dispensing module 128 may be oriented in order tooptimize delivery of the compound 104 to the subject 102. For example,in the case of an inhalable compound, the dispensing module may beoriented to optimize respiratory receipt by the subject 102. This mayinclude orienting the dispensing module 128 such that an outlet (nozzle)130 or jet emanating from the dispensing module 128 is pointed at(oriented towards) the nose 132 or mouth 134 of the subject 102.

Some inhalable compounds for utilization with the collar 100 mayinclude, but are not limited to inhalable insulin, an inhalablecorticosteroid, an inhalable antibiotic, an inhalable beta-2 agonist, oran inhalable mast cell stabilizer. Further, compounds for utilizationwith the collar 100 may include a compound that acts locally orsystemically. Compounds for utilization with the collar 100 may includea compound having a formulation such that the formulation includes acarrier, such as a gas carrier, a liquid carrier, or a solid carrier.Additionally, compounds for utilization with the collar 100 may includea compound having a formulation such that the formulation includespenetration or absorption enhancers. It should be noted that this listis provided by way of example only and is not meant to be restrictive ofthe present invention. Further, it will be appreciated that variousmechanisms or compounds may be utilized to power (e.g., nebulize) theinhalable compound out of the collar 100, such as O₂ (oxygen) orhelium-O₂ (heliox). Such compounds may be selected for improving theresponse of the subject (e.g., heliox when utilized with an inhaledbronchodilator such as an inhalable beta-2 agonist).

Further, the dispensing module 128 may be maintained in an optimalposition for optimizing delivery of the compound 104 to the subject 102.In an embodiment, a relative position or direction to a desiredrespiratory target is determined. For example, a direction to thesubject's nose 132 may be determined. In an embodiment, a position ofthe dispensing module 128 may then be maintained for optimizing deliveryof the compound 104. For example, the orientation of the outlet 130 maybe maintained in the direction determined for the subject's nose 132. Inan embodiment, the position of the dispensing module 128 may bemaintained via a weight 136. In an embodiment, the position of thedispensing module may be maintained via an adhesive 138. In anembodiment, the position of the dispensing module 128 may be maintainedvia a slide 140. In an embodiment, the position of the dispensing module128 may be maintained via a magnet 142. In an embodiment, the positionof the dispensing module 128 may be maintained via a fastener 144 (e.g.,a button or a snap). In an embodiment, the position of the dispensingmodule 128 may be maintained via a spring 146. It will be appreciatedthat this list is provided by way of example and is not meant to berestrictive of the present disclosure.

The delivery of the compound 104 can be controlled to optimize orregulate delivery of the material 104 to the subject 102. The deliverymechanism can be one or more of the same type of material deliverysystem (e.g., nebulizer), or may include at least two different deliverysystems (e.g., nebulizer and a dry powder inhaler), the at least oneoutlet 130 may be one of a suite or an array of outlets (e.g., nozzles)148. One or more outlets (e.g., the first nozzle 130 and a second nozzle150) may be selected to deliver the compound 104. In an embodiment, thefirst and second nozzles 130 and 150 may be in different locations. Thedirection of the subject's nose 132 may be determined. Then, a dischargedirection for the dispensing module 128 can be controlled for optimizingdelivery of the compound 104. For example, the orientation of thedispensing module 128 can be controlled to orient the first outlet 130and the second outlet 150 in the direction determined for the subject'snose 132. In an embodiment, directed delivery of the compound 104 may beaccomplished via a demand valve 152 coupled with programmable dosing. Inan embodiment, directed delivery of the compound 104 may be accomplishedvia a charged particle dispersion. In an embodiment, the first outlet130, the second outlet 150, or the suite of outlets 148 may includeoutlets having variable discharge characteristics, such as directional,volumetric, spray area, or other characteristics.

Various mechanical systems for delivering inhalable materials mayinclude, but are not limited to, a vaporizer (e.g., a device forvaporizing liquid material for inhalation), a nebulizer (e.g., a devicefor administering material in the form of a mist for inhalation), aliquid aerosol system (e.g., a system for propelling fine droplets ofmaterial utilizing a gas), a dry powder inhalation system, an atomizer(e.g., a device for reducing a liquid material to a spray or vapor forinhalation), a metered dose inhaler (e.g., a device for releasing ametered dose of material for inhalation), a propellant-delivered system,a piezo-electric inhaler (e.g., an inhaler utilizing a piezo vibrator todeaggregate a material powder for subsequent inhalation by the subject),etc. It is further contemplated that the material 104 may be provided inremovable or replaceable storage units. For example, the material 104may be provided in an easily replaceable dose packet. In an embodiment,the material 104 may be provided in a removable canister. It will beappreciated that these storage units are provided by way of example, andother various storage configurations having varying shapes, sizes, andform factors may be utilized with the collar 100.

Following are a series of flowcharts depicting implementations. For easeof understanding, the flowcharts are organized such that the initialflowcharts present implementations via an example implementation andthereafter the following flowcharts present alternate implementationsand/or expansions of the initial flowchart(s) as either sub-componentoperations or additional component operations building on one or moreearlier-presented flowcharts. Those having skill in the art willappreciate that the style of presentation utilized herein (e.g.,beginning with a presentation of a flowchart(s) presenting an exampleimplementation and thereafter providing additions to and/or furtherdetails in subsequent flowcharts) generally allows for a rapid and easyunderstanding of the various process implementations. In addition, thoseskilled in the art will further appreciate that the style ofpresentation used herein also lends itself well to modular and/orobject-oriented program design paradigms.

FIG. 2 illustrates an operational flow 200 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position. InFIG. 2 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1A through 1H, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIGS. 1Athrough 1H. Also, although the various operational flows are presentedin the sequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 200 moves to an operation210. Operation 210 depicts dispensing for inhalation by a user a dose ofan inhalable compound according to a dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may include amemory 154 for storing a dosing instruction set. The memory 154 may beconnected to a processor 156 operatively configured for initiating thedispensing of a dose 158 of a compound 104. In an embodiment, theprocessor 156 is connected to a pump 160. The processor 156 mayelectronically signal the pump 160 to dispense the dose 158 of thecompound 104.

Then, operation 220 depicts maintaining in physical association with theuser a hands-free article for dispensing an inhalable compound in anoperable dispensing position. For example, as shown in FIGS. 1A through1H, the collar 100 may be maintained in an operable position bypositioning a weight 136 at one end of the collar 100.

FIG. 3 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 3 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 302, an operation 304, an operation306, and/or an operation 308.

The operation 302 illustrates dispensing a dose of an inhalable compoundaccording to a defined dosing instruction set. For example, as shown inFIGS. 1A through 1H, the memory 154 may store a defined dosinginstruction set, and a processor 156 coupled with the memory 154 may beconfigured for initiating dispensing of the compound 104 according tothe dosing instruction set. Further, the operation 304 illustratesdispensing a dose of an inhalable compound according to a time defineddosing instruction set. For example, as shown in FIGS. 1A through 1H,the memory 154 may store a time defined dosing instruction set, and theprocessor 156 coupled with the memory 154 may be configured forinitiating dispensing of the compound 104 according to the time defineddosing instruction set. In an embodiment, the processor 156 is connectedto a time keeping module 162 for determining when to dispense thecompound 104. For example, the compound 104 may be dispensed while thesubject 102 is sleeping (or is scheduled to sleep according to the timedefined dosing instruction set). Alternatively, the compound 104 may bedispensed shortly before the subject is scheduled to sleep (e.g., in thecase of a compound including a sleep aid, or the like). Further, theoperation 306 illustrates dispensing a dose of an inhalable compoundaccording to a user defined dosing instruction set. For example, asshown in FIGS. 1A through 1H, the memory 154 may store a user defineddosing instruction set, and the processor 156 coupled with the memory154 may be configured for initiating dispensing of the compound 104according to the user defined dosing instruction set. In an embodiment,the collar 100 may include an interface 164 accessible by a user 166 forsupplying the user defined dosing instruction set to the memory 154(e.g., via the processor 156). Further, the operation 308 illustratesdispensing a dose of an inhalable compound according to a health careprovider-defined dosing instruction set. For example, as shown in FIGS.1A through 1H, the collar 100 may include an interface 164 accessible bya physician 168 for supplying a physician defined dosing instruction setto the memory 154 (e.g., via the processor 156).

FIG. 4 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 4 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 402, an operation 404, an operation406, and/or an operation 408. Further, the operation 402 illustratesdispensing a dose of an inhalable compound according to a need responsedosing instruction set. For example, as shown in FIGS. 1A through 1H,the collar 100 may include a memory 154 for storing a need responsedosing instruction set. The collar 100 may also include a transducer(e.g., a sensor module 170) for sensing a health or wellness-relatedcharacteristic (or another characteristic) of the subject 102. Based onthe sensed characteristic of the subject 102, the processor 156 may beoperatively configured to dispense the dose 158 of the compound 104after verifying that the characteristic corresponds to a need stored inthe need response dosing instruction set. In one instance, a sensedcharacteristic includes a blood glucose level, and the need responsedosing instruction set includes instructions for dispensing a dose ofthe compound when the sensed blood glucose level is above a certainthreshold. Further, the operation 404 illustrates dispensing a dose ofan inhalable compound according to an environmental need response dosinginstruction set. For example, as shown in FIGS. 1A through 1H, thecollar 100 may include a memory 154 for storing an environmental needresponse dosing instruction set. The collar 100 may also include asensor module 170 for sensing an environment occupied by the subject102. Based on the sensed environment of the subject 102, the processor156 may be operatively configured to dispense the dose 158 of thecompound 104 after verifying that the environment corresponds to anenvironment stored in the environmental need response dosing instructionset. In an embodiment, the sensed environment may include sensing anactual or likely trigger (e.g., an allergen, a chemical, an irritant, ora particulate). A likely trigger may include, for example, a sensedenvironment where the presence of an animal increases a likelihood ofdander, or an outside environment where a time of year (e.g., the monthof May) increases a likelihood of pollen exposure. In one instance, asensed environment includes an outdoor environment, and the environmentneed response dosing instruction set includes instructions fordispensing a dose of the compound when the outdoor environment issensed. In an embodiment, the sensed environment includes at least oneother individual (and possibly a number of other individuals, e.g., acrowd), and the environmental need response dosing instruction setincludes instructions for dispensing a dose of a vaccine when the otherindividual is sensed. In an embodiment, the environmental need responsedosing instruction set includes instructions for dispensing a dose of acalming agent or anti-anxiety medication when one or more otherindividuals are sensed. In an embodiment, the sensed environment doesnot include another individual, and the environmental need responsedosing instruction set includes instructions for dispensing a dose of avaccine when the absence of other individuals is sensed. Further, theoperation 406 illustrates dispensing a dose of an inhalable compoundaccording to a location need response dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may include amemory 154 for storing a location need response dosing instruction set.The collar 100 may also include a sensor module 170 for sensing alocation occupied by the subject 102. Based on the sensed location ofthe subject 102, the processor 156 may be operatively configured todispense the dose 158 of the compound 104 after verifying that thelocation corresponds to a location stored in the location need responsedosing instruction set. In one instance, a sensed location includes aschool zone, and the location need response dosing instruction setincludes instructions for dispensing a dose of the compound when theschool zone is sensed. In another instance, the sensed location includesa living space, and the location need response dosing instruction setincludes instructions for dispensing a dosage of a pheromone (or anothersubstance) for preventing a pet from urinating in the living space.Alternatively, the sensed location may include a litter box, and thedosing instruction set may include instructions for dispensing apheromone (or another substance) for enticing a pet to defecate in thelitter box. Further, the operation 408 illustrates dispensing theinhalable compound in accordance with a dispensing order received by adispensing module. For example, as shown in FIGS. 1A through 1H, thedispensing module 128 may receive a dispensing order from the processor156.

In an embodiment, the dispensing order may be dispatched upon the sensormodule 170 detecting a condition of the subject, such as an asthmaticincident (e.g., a narrowing of the subject's airways). In an embodiment,the sensor module 170 may identify a symptom of an asthmatic incident,such as a subject experiencing trouble breathing, a sneeze, a cough, awheeze, a rhonchus, or a snore. In an embodiment, the sensor module 170may identify a physical condition associated with an asthmatic incident,such as a narrowing of the subject's airways. Other symptoms orconditions detected by the sensor module 170 may include, but are notlimited to, Chronic Obstructive Pulmonary Disease (COPD), bronchitis,abnormally high blood glucose level, etc. Further, it will beappreciated that the processor 156 may determine the most effectiveroute of administration for a material based upon a particular conditionor set of symptoms. In an embodiment, the processor 156 may determinethat an inhalation route of delivery including the nasal cavity is amost effective route of treatment for an asthmatic incident, and mayinstruct administration of the dose 158 of the material 104 accordingly(e.g., in a case where the dose 158 includes a beta-2 agonist.) In anembodiment, the processor 156 may be programmed to determine whether ato-be-delivered agent should be provided to the subject via intra-nasaladministration or inhalation, or both. For example, for a desireddelivery of an agent to the brain of the subject, the device may beprogrammed to administer such agent through intranasal administration.

FIG. 5 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 5 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 502, an operation 504, and/or anoperation 506.

The operation 502 illustrates dispensing a dose of a nutraceuticalcompound. For example, as shown in FIGS. 1A through 1H, the compound 104may include a nutraceutical compound 172.

The operation 504 illustrates dispensing a dose of a therapeuticcompound. For example, as shown in FIGS. 1A through 1H, the compound 104may include a therapeutic compound 174.

The operation 506 illustrates dispensing a dose of a homeopathiccompound. For example, as shown in FIGS. 1A through 1H, the compound 104may include a homeopathic compound 176.

FIG. 6 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 6 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 602, an operation 604, and/or anoperation 606.

The operation 602 illustrates generating an aerosol of the inhalablecompound. For example, as shown in FIGS. 1A through 1H, the compound 104may include an aerosol which may be dispensed via the nozzle 130.

The operation 604 illustrates generating at least one of a vapor or apowder of the inhalable compound. For example, as shown in FIGS. 1Athrough 1H, the compound 104 may include a vapor which may be dispensedvia the suite of nozzles 148. Alternatively, the compound 104 mayinclude a powder, which may be dispensed via the suite of nozzles 148.Generating a powder may include, for example, generating particles, fineparticles, micronized particles, microparticles, or particulates.

The operation 606 illustrates generating a liquid atomization of theinhalable compound. For example, as shown in FIGS. 1A through 1H, thecompound 104 may include an atomized liquid which may be dispensed viathe nozzle 130.

FIG. 7 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 7 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 702, an operation 704, an operation706, and/or an operation 708.

The operation 702 illustrates administering the inhalable compound viaspraying a compound. For example, as shown in FIGS. 1A through 1H, thecompound 104 may be sprayed via the nozzle 130.

The operation 704 illustrates administering the inhalable compound viaat least one of dusting or powderizing a compound. For example, as shownin FIGS. 1A through 1H, the compound 104 may be dusted via the nozzle130. Powderizing the compound may include, for example,de-agglomeration, or particularizing.

The operation 706 illustrates administering the inhalable compound vianebulizing a compound. For example, as shown in FIGS. 1A through 1H, thecompound 104 may be nebulized and dispensed via the nozzle 130.

The operation 708 illustrates administering the inhalable compound viavaporizing a compound. For example, as shown in FIGS. 1A through 1H, thecompound 104 may be vaporized and dispensed via the nozzle 130.

In an embodiment, the inhalable compound may include a carrier. Forexample, a carrier may include a gas carrier, a liquid carrier, or asolid carrier. In embodiments, the carrier may include a hydrocarbon, afluorocarbon, a propellant, a salt, a saccharide, a lipid, a liposome, asynthetic, or a natural polymer. Further, various formulations includinga carrier may include penetration or absorption enhancers.

FIG. 8 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 8 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 802, an operation 804, an operation806, and/or an operation 808.

The operation 802 illustrates receiving a dose of a pharmaceuticalcompound for dispensing. For example, as shown in FIGS. 1A through 1H,the compound 104 may include a pharmaceutical compound 178. Thepharmaceutical compound 178 may be stored in a reservoir 180 of thecollar 100. The reservoir 180 may receive one or more doses of thepharmaceutical compound 178 for dispensing.

The operation 804 illustrates receiving a dose of a therapeutic compoundfor dispensing. For example, as shown in FIGS. 1A through 1H, thecompound 104 may include a therapeutic compound 174. The therapeuticcompound 174 may be stored in a reservoir 180 of the collar 100. Thereservoir 180 may receive one or more doses of the therapeutic compound174 for dispensing. Further, the operation 806 illustrates receiving adosing instruction set. For example, as shown in FIGS. 1A through 1H,the dosing instruction set may be received via the interface 164.Further, the operation 808 illustrates receiving a dosing instructionset via a wireless transmission. For example, as shown in FIGS. 1Athrough 1H, the dosing instruction set may be received via the interface164, which may include a wireless interface for receiving a wirelesstransmission.

FIG. 9 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 9 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 902, and/or an operation 904.Further, the operation 902 illustrates receiving a dosing instructionset via a processor. For example, as shown in FIGS. 1A through 1H, theprocessor 156 may receive a dosing instruction set. Further, theoperation 904 illustrates receiving a dosing instruction set via aconnectable device containing digital instructions or data. For example,as shown in FIGS. 1A through 1H, the collar 100 may receive a dosinginstruction set from a connectable device 182 (e.g., a laptop computer,a personal digital assistant (PDA), or a cellular telephone).

FIG. 10 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 10 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1002, and/or an operation 1004.Further, the operation 1002 illustrates receiving a dosing instructionset via a wire transmission. For example, as shown in FIGS. 1A through1H, the device 182 may be connected to the interface 164 via a wiredconnection. Further, the operation 1004 illustrates receiving a dosinginstruction set via an optical transmission. For example, as shown inFIGS. 1A through 1H, the device 182 may be connected to the interface164 via an optical connection. For instance, the device 182 may includean optical transmitter (e.g., a light), and the interface 164 mayinclude an optical receiver (e.g., a light sensor).

FIG. 11 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 11 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1102, and/or an operation 1104.Further, the operation 1102 illustrates receiving a dosing instructionset via a radio transmission. For example, as shown in FIGS. 1A through1H, the device 182 may be connected to the interface 164 via a radioconnection. For instance, the device 182 may include a Radio Frequency(RF) transmitter, and the interface 164 may include an RF receiver.Further, the operation 1104 illustrates receiving a dosing instructionset via a mechanical transmission. For example, as shown in FIGS. 1Athrough 1H, the device 182 may be connected to the interface 164 via amechanical connection.

FIG. 12 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 12 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1202, and/or an operation 1204.Further, the operation 1202 illustrates receiving a dosing instructionset from a user. For example, as shown in FIGS. 1A through 1H, theinterface 164 may be utilized to receive a dosing instruction set from auser 166. Further, the operation 1204 illustrates receiving a dosinginstruction set from a health care provider. A health care provider mayinclude, for example, a physician, a physician's assistant, a nurse, anurse practitioner, a pharmacist, or an emergency medical technician.For example, as shown in FIGS. 1A through 1H, the interface 164 may beutilized to receive a dosing instruction set from a physician 168.

FIG. 13 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 13 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1302, and/or an operation 1304.Further, the operation 1302 illustrates receiving a dosing instructionset from a pharmacist. For example, as shown in FIGS. 1A through 1H, theinterface 164 may be utilized to receive a dosing instruction set from apharmacist 184. Further, the operation 1304 illustrates receiving adosing instruction set from at least one of a parent or a guardian. Forexample, as shown in FIGS. 1A through 1H, the interface 164 may beutilized to receive a dosing instruction set from a parent 186.

FIG. 14 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 14 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1402, and/or an operation 1404.Further, the operation 1402 illustrates receiving a dosing instructionset from at least one of a pet owner, an animal researcher, or an animalowner. For example, as shown in FIGS. 1A through 1H, the interface 164may be utilized to receive a dosing instruction set from a pet owner188. Further, the operation 1404 illustrates receiving a dosinginstruction set from a veterinarian health care provider. A veterinarianhealth care provider may include, among others, a veterinarian, aveterinarian's assistant, or a veterinarian technician. For example, asshown in FIGS. 1A through 1H, the interface 164 may be utilized toreceive a dosing instruction set from a veterinarian 190. In anembodiment, the interface 164, may be utilized to receive a dosinginstruction set from a researcher.

FIG. 15 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 15 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1502. Further, the operation 1502illustrates receiving a dosing instruction set from a medical responseunit. For example, as shown in FIGS. 1A through 1H, the interface 164may be utilized to receive a dosing instruction set from a medicalresponse unit 192.

FIG. 16 illustrates alternative embodiments of the example operationalflow 5600 of FIG. 56. FIG. 16 illustrates example embodiments where theoperation 5630 may include at least one additional operation. Additionaloperations may include an operation 1602, and/or an operation 1604.

The operation 1602 illustrates receiving a dose of a homeopathiccompound for dispensing. For example, as shown in FIGS. 1A through 1H,the compound 104 may include one or more homeopathic compounds 176.

The operation 1604 illustrates receiving a dose of a nutraceticalcompound for dispensing. For example, as shown in FIGS. 1A through 1H,the compound 104 may include one or more nutraceutical compounds 172.

FIG. 17 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 17 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 1702, an operation 1704, and/or anoperation 1706.

The operation 1702 illustrates receiving the inhalable compound in areservoir. For example, as shown in FIGS. 1A through 1H, the compound104 may be received in a reservoir 180. Further, the operation 1704illustrates monitoring a quantity of the inhalable compound in thereservoir. For example, as shown in FIGS. 1A through 1H, the processor156 may be utilized to monitor the compound 104 in the reservoir 180.Further, the operation 1706 illustrates logging a quantity of theinhalable compound in the reservoir. For example, as shown in FIGS. 1Athrough 1H, the processor 156 may be utilized to monitor the compound104 in the reservoir 180, and the memory 154 may be utilized to keep alog of a quantity of the compound 104 in the reservoir 180.

FIG. 18 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 18 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 1802, and/or an operation 1804.Further, the operation 1802 illustrates logging a quantity of theinhalable compound dispensed from the reservoir. For example, as shownin FIGS. 1A through 1H, the processor 156 may be utilized to monitor anamount of the compound 104 dispensed from the reservoir 180, and thememory 154 may be utilized to keep a log of a quantity of the compound104 dispensed from the reservoir 180. Further, the operation 1804illustrates logging a time of the inhalable compound dispensed from thereservoir. For example, as shown in FIGS. 1A through 1H, the processor156 may be utilized to monitor a time of dispensing the compound 104from the reservoir 180 (e.g., by utilizing the time keeping module 162),and the memory 154 may be utilized to keep a log of a time of dispensingthe compound 104 from the reservoir 180.

FIG. 19 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 19 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 1902, and/or an operation 1904.Further, the operation 1902 illustrates logging a dispersion pattern ofthe inhalable compound dispensed from the reservoir. For example, asshown in FIGS. 1A through 1H, the collar 100 may include a camera 194for monitoring a dispersion pattern of the dispensed compound 104, andthe memory 154 may be utilized to log the dispersion pattern. Further,the operation 1904 illustrates logging a species of the inhalablecompound dispensed from the reservoir. For example, as shown in FIGS. 1Athrough 1H, the processor 156 may be utilized to determine a species ofthe compound 104 dispensed from the reservoir 180, and the memory 154may be utilized to log the determined species.

FIG. 20 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 20 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2002. Further, the operation 2002illustrates transmitting a set of logged reservoir information to anexternal location. For example, as shown in FIGS. 1A through 1H, theinformation logged by the memory 154 may be transmitted to an externallocation via the interface 164.

FIG. 21 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 21 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2102, and/or an operation 2104.Further, the operation 2102 illustrates activating an alert when aquantity threshold of the inhalable compound in the reservoir isachieved. For example, as shown in FIGS. 1A through 1H, the collar 100may include a visual indicator 196 for issuing an alert when a quantitythreshold of the compound 104 is achieved (e.g., as determined by theprocessor 156). Further, the operation 2104 illustrates activating avisual alert when a quantity threshold of the inhalable compound in thereservoir is achieved. For example, as shown in FIGS. 1A through 1H, thevisual indicator 196 may be activated when a quantity threshold of thecompound 104 is achieved.

FIG. 22 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 22 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2202. Further, the operation 2202illustrates activating an auditory alert when a quantity threshold ofthe inhalable compound in the reservoir is achieved. For example, asshown in FIGS. 1A through 1H, the collar 100 may include an audibleindicator 198 for issuing an auditory alert when a quantity threshold ofthe compound 104 is achieved.

FIG. 23 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 23 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2302. Further, the operation 2302illustrates activating an electronic alert when a quantity threshold ofthe inhalable compound in the reservoir is achieved. For example, asshown in FIGS. 1A through 1H, the collar 100 may include an electronicindicator 50 for issuing an electronic alert when a quantity thresholdof the compound 104 is achieved.

FIG. 24 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 24 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2402, an operation 2404, and/or anoperation 2406.

The operation 2402 illustrates receiving the inhalable compound in areloadable reservoir. For example, as shown in FIGS. 1A through 1H, thereservoir 180 may include one or more reloadable reservoirs.

The operation 2404 illustrates receiving the inhalable compound in atleast one of a disposable reservoir or a multi-component reservoir. Forexample, as shown in FIGS. 1A through 1H, the reservoir 180 may includeone or more disposable reservoirs.

The operation 2406 illustrates receiving the inhalable compound in amulti-compound reservoir. For example, as shown in FIGS. 1A through 1H,the reservoir 180 may include one or more compounds, such as a firstcompound 104 and a second compound.

FIG. 25 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 25 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2502, an operation 2504, and/or anoperation 2506.

The operation 2502 illustrates receiving the inhalable compound in asingle compound reservoir. For example, as shown in FIGS. 1A through 1H,the reservoir 180 may include a single compound, such as the firstcompound 104.

The operation 2504 illustrates receiving the inhalable compound in adispensing reservoir. For example, as shown in FIGS. 1A through 1H, thecompound 104 received in the reservoir 180 may be an inhalable compound.

The operation 2506 illustrates receiving the inhalable compound in amodular reservoir. For example, as shown in FIGS. 1A through 1H, thereservoir 180 may include a module reservoir.

FIG. 26 illustrates alternative embodiments of the example operationalflow 5700 of FIG. 57. FIG. 26 illustrates example embodiments where theoperation 5730 may include at least one additional operation. Additionaloperations may include an operation 2602, and/or an operation 2604.

The operation 2602 illustrates receiving the inhalable compound in aprogrammable reservoir. For example, as shown in FIGS. 1A through 1H,the reservoir 180 may include a programmable reservoir, which may beprogrammable via the processor 156.

The operation 2604 illustrates receiving the inhalable compound in aweighted reservoir. For example, as shown in FIGS. 1A through 1H, thereservoir 180 may include a weighted reservoir, which may be weightedwith a weight 136.

FIG. 27 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 27 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 2702, an operation 2704, and/or anoperation 2706.

The operation 2702 illustrates disposing the hands-free aerosol deliverysystem substantially around a portion of the body of a mammal. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may encirclethe neck portion 106 of a subject 102. Further, the operation 2704illustrates encircling a neck portion of the body of a mammal with asupport member of the hands-free aerosol delivery device. For example,as shown in FIGS. 1A through 1H, the collar 100 may encircle the neckportion 106 of a subject 102. Further, the operation 2706 illustratesencircling a wrist portion of the body of a mammal with a support memberof the hands-free aerosol delivery device. For example, as shown inFIGS. 1A through 1H, the collar 100 may encircle the wrist portion 108of a subject 102.

FIG. 28 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 28 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 2802, and/or an operation 2804.Further, the operation 2802 illustrates encircling a chest portion ofthe body of a mammal with a support member of the hands-free aerosoldelivery device. For example, as shown in FIGS. 1A through 1H, thecollar 100 may encircle a chest portion 110 of the subject 102. Further,the operation 2804 illustrates encircling a head portion of the body ofa mammal with a support member of the hands-free aerosol deliverydevice. For example, as shown in FIGS. 1A through 1H, the collar 100 mayencircle a head portion 112 of the subject 102.

FIG. 29 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 29 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 2902, and/or an operation 2904.Further, the operation 2902 illustrates connecting a first end of asupport member of a hands-free aerosol delivery device to a second endof a support member of a hands-free aerosol delivery device whilecreating a circle about the body part of a mammal. For example, as shownin FIGS. 1A through 1H, the collar 100 may comprise a support memberhaving a first end 114 and a second end 116. The first end 114 may beconnected to the second end 116, encircling and creating a closed loop(e.g., a circle) about the body part of the subject 102. Further, theoperation 2904 illustrates connecting the first end of a support memberof the hands-free aerosol delivery device to the second end of a supportmember of the hands-free aerosol delivery device via a magnet. Forexample, as shown in FIGS. 1A through 1H, the first end 114 may beconnected to the second end 116 via a magnet 118.

FIG. 30 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 30 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 3002. Further, the operation 3002illustrates connecting the first end of a support member of thehands-free aerosol delivery device to the second end of a support memberof the hands-free aerosol delivery device via a hook. For example, asshown in FIGS. 1A through 1H, the first end 114 of the collar 100 may beconnected to the second end 116 of the collar 100 via a hook 120.

FIG. 31 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 31 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 3102. Further, the operation 3102illustrates connecting the first end of a support member of thehands-free aerosol delivery device to the second end of a support memberof the hands-free aerosol delivery device via a snap connection. Forexample, as shown in FIGS. 1A through 1H, the first end 114 may beconnected to the second end 116 via a snap connection 122.

FIG. 32 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 32 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 3202. Further, the operation 3202illustrates connecting the first end of a support member of thehands-free aerosol delivery device to the second end of a support memberof the hands-free aerosol delivery device via a threaded connection. Forexample, as shown in FIGS. 1A through 1H, the first end 114 of thecollar 100 may be connected to the second end 116 of the collar 100 viaa threaded connection 124.

FIG. 33 illustrates alternative embodiments of the example operationalflow 5900 of FIG. 59. FIG. 33 illustrates example embodiments where theoperation 5930 may include at least one additional operation. Additionaloperations may include an operation 3302. Further, the operation 3302illustrates connecting the first end of a support member of thehands-free aerosol delivery device to the second end of a support memberof the hands-free aerosol delivery device via a belt-like connection.For example, as shown in FIGS. 1A through 1H, the first end 114 may beconnected to the second end 116 via a belt-like connection 126.

FIG. 34 illustrates alternative embodiments of the example operationalflow 6000 of FIG. 60. FIG. 34 illustrates example embodiments where theoperation 6010 may include at least one additional operation. Additionaloperations may include an operation 3402, an operation 3404, and/or anoperation 3406.

The operation 3402 illustrates detecting a blood glucose level in themammal. For example, as shown in FIGS. 1A through 1H, the sensor module170 may be utilized to detect a blood glucose level in the subject 102.

The operation 3404 illustrates detecting a blood oxygen level in themammal. For example, as shown in FIGS. 1A through 1H, the sensor module170 may be utilized to detect a blood oxygen level in the subject 102.

The operation 3406 illustrates detecting an infection in the mammal. Forexample, as shown in FIGS. 1A through 1H, the sensor module 170 may beutilized to detect an infection in the subject 102.

FIG. 35 illustrates alternative embodiments of the example operationalflow 6000 of FIG. 60. FIG. 35 illustrates example embodiments where theoperation 6010 may include at least one additional operation. Additionaloperations may include an operation 3502, an operation 3504, and/or anoperation 3506.

The operation 3502 illustrates detecting vascular dysfunction in themammal. For example, as shown in FIGS. 1A through 1H, the sensor module170 may be utilized to detect a vascular dysfunction in the subject 102.

The operation 3504 illustrates detecting blood flow in the mammal. Forexample, as shown in FIGS. 1A through 1H, the sensor module 170 may beutilized to detect blood flow in the subject 102.

The operation 3506 illustrates detecting respiratory minute volume inthe mammal. For example, as shown in FIGS. 1A through 1H, the sensormodule 170 may be utilized to detect a respiratory volume in the subject102. In an embodiment, the sensor module 170 may be utilized to detect asneeze of the subject 102. In an embodiment, the sensor module 170 maybe utilized to detect a cough of the subject 102. In an embodiment, thesensor module 170 may be utilized to detect a wheeze of the subject 102.In an embodiment, the sensor module 170 may be utilized to detect arhonchus of the subject 102. In an embodiment, the sensor module 170 maybe utilized to detect a snore of the subject 102. In an embodiment, thesensor module 170 may be utilized to detect a temperature (e.g., a bodytemperature) of the subject 102. In an embodiment, the sensor module 170may be utilized to detect an expelled gas from the subject 102, such asa gas exhaled by the subject.

FIG. 36 illustrates an operational flow 3600 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 36 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 3610.

After a start operation, an operation 210, and an operation 220, theoperational flow 3600 moves to an operation 3610. Operation 3610illustrates dispensing a dose of a pharmaceutical compound. For example,as shown in FIGS. 1A through 1H, the collar 100 may be utilized todispense a dose 158 of a pharmaceutical compound 178 to the subject 102.

FIG. 37 illustrates an operational flow 3700 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 37 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 3710.

After a start operation, an operation 210, and an operation 220, theoperational flow 3700 moves to an operation 3710. Operation 3710illustrates directing issuance of a dispensing order. For example, asshown in FIGS. 1A through 1H, the processor 156 may direct issuance of adispensing order (e.g., to the pump 160).

FIG. 38 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 38 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 3802, an operation 3804, and/or anoperation 3806. Further, the operation 3802 illustrates accepting adosing instruction set from a user. For example, as shown in FIGS. 1Athrough 1H, the interface 164 may be utilized to receive a dosinginstruction set from a user 166. Further, the operation 3804 illustratesaccepting a dosing instruction set from at least one of a physician, ahealth care provider, a physician's assistant, a nurse, a nursepractitioner, a registered nurse, a licensed practical nurse, apharmacist, or an emergency responder. For example, as shown in FIGS. 1Athrough 1H, the interface 164 may be utilized to receive a dosinginstruction set from a physician 168. Further, the operation 3806illustrates accepting a dosing instruction set from a medical responseunit. For example, as shown in FIGS. 1A through 1H, the interface 164may be utilized to receive a dosing instruction set from a medicalresponse unit 192.

FIG. 39 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 39 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 3902, an operation 3904, and/or anoperation 3906. Further, the operation 3902 illustrates validating adosing instruction set for performing a function. For example, as shownin FIGS. 1A through 1H, the processor 156 may be utilized to validate adosing instruction set (e.g., by check the dosing instruction setagainst information stored in the memory 154). Further, the operation3904 illustrates translating a dosing instruction set for performing afunction into a dispensing order. For example, as shown in FIGS. 1Athrough 1H, the processor 156 may be utilized to translate a dosinginstruction set into a dispensing order (e.g., by referencing the dosinginstruction set to a lookup table stored in the memory 154). Further,the operation 3906 illustrates translating a medical parameter into adispensing order. For example, as shown in FIGS. 1A through 1H, theprocessor 156 may be utilized to translate a medical parameter into adispensing order (e.g., by referencing the medical parameter to a lookuptable stored in the memory 154).

FIG. 40 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 40 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 4002, an operation 4004, and/or anoperation 4006. Further, the operation 4002 illustrates generating adispensing order according to the instruction set from a user. Forexample, as shown in FIGS. 1A through 1H, the processor 156 may beutilized to generate a dispensing order according to an instruction setfrom a user 166 stored in the memory 154. Further, the operation 4004illustrates generating a dispensing order according to the instructionset from a health care professional. For example, as shown in FIGS. 1Athrough 1H, the processor 156 may be utilized to generate a dispensingorder according to an instruction set from a physician 168 stored in thememory 154. Further, the operation 4006 illustrates generating adispensing order according to the instruction set from a medicalresponse unit. For example, as shown in FIGS. 1A through 1H, theprocessor 156 may be utilized to generate a dispensing order accordingto an instruction set from a medical response unit 192 stored in thememory 154.

FIG. 41 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 41 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 4102. Further, the operation 4102illustrates requesting a dose of the inhalable compound in accordancewith a dispensing order received by a dispensing module from areservoir. For example, as shown in FIGS. 1A through 1H, the dispensingmodule 128 may receive a request from the reservoir 180 for a dose ofthe compound 104.

FIG. 42 illustrates an operational flow 4200 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 42 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4210.

After a start operation, an operation 210, and an operation 220, theoperational flow 4200 moves to an operation 4210. Operation 4210illustrates transmitting a dispensing order to a dispensing module. Forexample, as shown in FIGS. 1A through 1H, the processor 156 may transmita dispensing order to the dispensing module 128 (e.g., to the reservoir180).

FIG. 43 illustrates an operational flow 4300 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 43 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4310.

After a start operation, an operation 210, and an operation 220, theoperational flow 4300 moves to an operation 4310. Operation 4310illustrates transmitting a dispensing order to a dispensing module via awireless transmission. For example, as shown in FIGS. 1A through 1H, thedispensing module 128 may receive a dispensing order from a physician168 via a wireless transmission received by the interface 164.

FIG. 44 illustrates an operational flow 4400 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 44 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4410.

After a start operation, an operation 210, and an operation 220, theoperational flow 4400 moves to an operation 4410. Operation 4410illustrates transmitting a dispensing order to a dispensing module viaan optical transmission. For example, as shown in FIGS. 1A through 1H,the dispensing module 128 may receive a dispensing order from aphysician 168 via an optical transmission received by the interface 164.

FIG. 45 illustrates an operational flow 4500 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 45 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4510.

After a start operation, an operation 210, and an operation 220, theoperational flow 4500 moves to an operation 4510. Operation 4510illustrates transmitting a dispensing order to a dispensing module via awire transmission. For example, as shown in FIGS. 1A through 1H, thedispensing module 128 may receive a dispensing order from a physician168 via an wire transmission received by the interface 164.

FIG. 46 illustrates an operational flow 4600 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 46 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4610.

After a start operation, an operation 210, and an operation 220, theoperational flow 4600 moves to an operation 4610. Operation 4610illustrates transmitting a dispensing order to a dispensing module via amechanical transmission. For example, as shown in FIGS. 1A through 1H,the dispensing module 128 may receive a dispensing order from aphysician 168 via a mechanical transmission received by the interface164.

FIG. 47 illustrates an operational flow 4700 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 47 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4710.

After a start operation, an operation 210, and an operation 220, theoperational flow 4700 moves to an operation 4710. Operation 4710illustrates transmitting a dispensing order to a dispensing module via aradio transmission. For example, as shown in FIGS. 1A through 1H, thedispensing module 128 may receive a dispensing order from a physician168 via a radio transmission received by the interface 164.

FIG. 48 illustrates an operational flow 4800 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 48 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4810.

After a start operation, an operation 210, and an operation 220, theoperational flow 4800 moves to an operation 4810. Operation 4810illustrates transmitting a dispensing order to a dispensing module via aprocessor transmission. For example, as shown in FIGS. 1A through 1H,the dispensing module 128 may receive a dispensing order from theprocessor 156.

FIG. 49 illustrates an operational flow 4900 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 49 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 4910, an operation 4912,an operation 4914, and/or an operation 4916.

After a start operation, an operation 210, and an operation 220, theoperational flow 4900 moves to an operation 4910. Operation 4910illustrates controlling delivery of an inhalable compound. For example,as shown in FIGS. 1A through 1H, the demand valve 152 may be utilized tocontrol delivery of the compound 104.

The operation 4912 illustrates selecting one or more delivery nozzlesfrom a suite of nozzles. For example, as shown in FIGS. 1A through 1H,the second nozzle 150 may be selected from the suite of nozzles 148.

The operation 4914 illustrates directing delivery of the inhalablecompound from one or more nozzles at different locations. For example,as shown in FIGS. 1A through 1H, the compound 104 may be delivered fromthe first nozzle 130 or the second nozzle 150.

The operation 4916 illustrates directing delivery of the inhalablecompound by controlling a discharge direction. For example, as shown inFIGS. 1A through 1H, the direction of the subject's nose 132 may becalculated. Then, a discharge direction for the dispensing module 128may be controlled for optimizing delivery of the compound 104.

FIG. 50 illustrates alternative embodiments of the example operationalflow 4900 of FIG. 49. FIG. 50 illustrates example embodiments where theoperation 4910 may include at least one additional operation. Additionaloperations may include an operation 5002, an operation 5004, and/or anoperation 5006.

The operation 5002 illustrates directing delivery via a demand valvecoupled with programmable dosing. For example, as shown in FIGS. 1Athrough 1H, the demand valve 152 may be operatively configured todispense the compound 104 in accordance with a dosing schedule stored inthe memory 154.

The operation 5004 illustrates directing delivery via a charged particledispersion. For example, as shown in FIGS. 1A through 1H, the dispensingmodule 128 may dispense the compound 104 as a charged particledispersion.

The operation 5006 illustrates directing delivery via a nozzlecomprising variable discharge characteristics. For example, as shown inFIGS. 1A through 1H, the first nozzle 130, the second nozzle 150, or thesuite of nozzles 148 may include nozzles having variable dischargecharacteristics, such as directional, volumetric, spray area, or othercharacteristics.

FIG. 51 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 51 illustrates example embodiments where theoperation 220 may include at least one additional operation. Additionaloperations may include an operation 5102, an operation 5104, and/or anoperation 5106.

The operation 5102 illustrates orienting a dispensing module to optimizerespiratory receipt of an inhalable compound. For example, as shown inFIGS. 1A through 1H, the dispensing module 128 may be maintained in anoptimal position for optimizing delivery of the compound 104 to thesubject 102.

The operation 5104 illustrates maintaining a dispensing module inposition to optimize respiratory receipt of an inhalable compound. Forexample, as shown in FIGS. 1A through 1H, the orientation of the nozzle130 may be maintained in the direction determined for the subject's nose132.

The operation 5106 illustrates determining a relative position ordirection to a desired respiratory target. For example, as shown inFIGS. 1A through 1H, the direction to the subject's nose 132 may becalculated.

FIG. 52 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 52 illustrates example embodiments where theoperation 220 may include at least one additional operation. Additionaloperations may include an operation 5202, an operation 5204, and/or anoperation 5206.

The operation 5202 illustrates maintaining a position of the dispensingmodule via a weight. For example, as shown in FIGS. 1A through 1H, theposition of the dispensing module 128 may be maintained via a weight136.

The operation 5204 illustrates maintaining a position of the dispensingmodule via an adhesive. For example, as shown in FIGS. 1A through 1H,the position of the dispensing module may be maintained via an adhesive138.

The operation 5206 illustrates maintaining a position of the dispensingmodule via a slide. For example, as shown in FIGS. 1A through 1H, theposition of the dispensing module 128 may be maintained via a slide 140.

FIG. 53 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 53 illustrates example embodiments where theoperation 220 may include at least one additional operation. Additionaloperations may include an operation 5302, an operation 5304, and/or anoperation 5306.

The operation 5302 illustrates maintaining a position of the dispensingmodule via a magnet. For example, as shown in FIGS. 1A through 1H, theposition of the dispensing module 128 may be maintained via a magnet142.

The operation 5304 illustrates maintaining a position of the dispensingmodule via a fastener. For example, as shown in FIGS. 1A through 1H, theposition of the dispensing module 128 may be maintained via a fastener144 (e.g., a button or a snap).

The operation 5306 illustrates maintaining a position of the dispensingmodule via a spring. For example, as shown in FIGS. 1A through 1H, theposition of the dispensing module 128 may be maintained via a spring146.

FIG. 54 illustrates an operational flow 5400 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 54 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 5410, an operation 5412,an operation 5414, and/or an operation 5416.

After a start operation, an operation 210, and an operation 220, theoperational flow 5400 moves to an operation 5410. Operation 5410illustrates dispensing a tracer compound in association with theinhalable compound. For example, as shown in FIGS. 1A through 1H, thecompound 104 may comprise an inhalable compound 52 and one or moretracer compounds.

The operation 5412 illustrates dispensing a visual tracer compound. Forexample, as shown in FIGS. 1A through 1H, the compound 104 may include avisual tracer 54.

The operation 5414 illustrates dispensing an olfactory tracer compound.For example, as shown in FIGS. 1A through 1H, the compound 104 mayinclude an olfactory tracer 56.

The operation 5416 illustrates dispensing a tastable tracer compound.For example, as shown in FIGS. 1A through 1H, the compound 104 mayinclude a tastable tracer 58.

FIG. 55 illustrates an operational flow 5500 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 55 illustrates an example embodiment where the example operationalflow 200 of FIG. 2 may include at least one additional operation.Additional operations may include an operation 5510, an operation 5512,an operation 5514, an operation 5516, and/or an operation 5518.

After a start operation, an operation 210, and an operation 220, theoperational flow 5500 moves to an operation 5510. Operation 5510illustrates providing an externally observable indication of dispensingof the inhalable compound. For example, as shown in FIGS. 1A through 1H,the collar 100 may include a visual indicator 196 for indicatingdispensing of the inhalable compound.

The operation 5512 illustrates providing a visual indication ofdispensing of the inhalable compound. For example, as shown in FIGS. 1Athrough 1H, the collar 100 may include the visual indicator 196 forindicating dispensing of the inhalable compound.

The operation 5514 illustrates providing a auditory indication ofdispensing of the inhalable compound. For example, as shown in FIGS. 1Athrough 1H, the collar 100 may include an audible indicator 198.

The operation 5516 illustrates providing a vibrational indication ofdispensing of the inhalable compound. For example, as shown in FIGS. 1Athrough 1H, the collar 100 may include a vibrational indicator 60.

The operation 5518 illustrates providing an electromagnetic indicationof dispensing of the inhalable compound. For example, as shown in FIGS.1A through 1H, the collar 100 may include an electromagnetic indicator62.

FIG. 56 illustrates an operational flow 5600 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position. InFIG. 56 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1A through 1H, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIGS. 1Athrough 1H. Also, although the various operational flows are presentedin the sequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 5600 moves to an operation5610. Operation 5610 depicts dispensing for inhalation by a user a doseof an inhalable compound according to a dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may dispense adose 158 of a compound 104 according to a dosing instruction set storedin a memory 154.

Then, operation 5620 depicts maintaining in physical association withthe user a hands-free article for dispensing an inhalable compound in anoperable dispensing position. For example, as shown in FIGS. 1A through1H, the collar 100 may be maintained in an operable dispensing positionwith an adhesive 138.

Then, operation 5630 depicts receiving the dose of the inhalablecompound for dispensing. For example, as shown in FIGS. 1A through 1H,the compound 104 may be received via the reservoir 180.

FIG. 57 illustrates an operational flow 5700 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position. InFIG. 57 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1A through 1H, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIGS. 1Athrough 1H. Also, although the various operational flows are presentedin the sequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 5700 moves to an operation5710. Operation 5710 depicts dispensing for inhalation by a user a doseof an inhalable compound according to a dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may dispense adose 158 of a compound 104 according to a dosing instruction set storedin a memory 154.

Then, operation 5720 depicts maintaining in physical association withthe user a hands-free article for dispensing an inhalable compound in anoperable dispensing position. For example, as shown in FIGS. 1A through1H, the collar 100 may be maintained in an operable dispensing positionwith an adhesive 138.

Then, operation 5730 depicts receiving the inhalable compound. Forexample, as shown in FIGS. 1A through 1H, the compound 104 may bereceived via the reservoir 180.

FIG. 58 illustrates an operational flow 5800 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 58 illustrates an example embodiment where the example operationalflow 5700 of FIG. 57 may include at least one additional operation.Additional operations may include an operation 5810.

After a start operation, an operation 5710, an operation 5720, and anoperation 5730, the operational flow 5800 moves to an operation 5810.Operation 5810 illustrates containing the inhalable compound in areservoir. For example, as shown in FIGS. 1A through 1H, the compound104 may be contained in the reservoir 180.

FIG. 59 illustrates an operational flow 5900 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position. InFIG. 59 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1A through 1H, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIGS. 1Athrough 1H. Also, although the various operational flows are presentedin the sequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 5900 moves to an operation5910. Operation 5910 depicts dispensing for inhalation by a user a doseof an inhalable compound according to a dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may dispense adose 158 of a compound 104 according to a dosing instruction set storedin a memory 154.

Then, operation 5920 depicts maintaining in physical association withthe user a hands-free article for dispensing an inhalable compound in anoperable dispensing position. For example, as shown in FIGS. 1A through1H, the collar 100 may be maintained in an operable dispensing positionwith an adhesive 138.

Then, operation 5930 depicts supporting a hands-free aerosol deliverysystem on the body of a mammal. For example, as shown in FIGS. 1Athrough 1H, the collar 100 may be supported on the body of the subject102.

FIG. 60 illustrates an operational flow 6000 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position. InFIG. 60 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1A through 1H, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIGS. 1Athrough 1H. Also, although the various operational flows are presentedin the sequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 6000 moves to an operation6010. Operation 6010 depicts detecting a medical condition parameter ofa mammal according to a medical condition parameter request. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may utilize asensor module 170 to detect a medical condition parameter for thesubject 102 according to a request from a physician 168. The request maybe received via the interface 164 and then transferred to the sensormodule 170 via the processor 156.

Then, operation 6020 depicts maintaining in physical association with auser a hands-free article for dispensing an inhalable compound in anoperable dispensing position. For example, as shown in FIGS. 1A through1H, the collar 100 may be maintained in an operable dispensing positionwith an adhesive 138.

Then, operation 6030 depicts dispensing for inhalation by the user adose of an inhalable compound according to a dosing instruction set. Forexample, as shown in FIGS. 1A through 1H, the collar 100 may dispense adose 158 of a compound 104 according to a dosing instruction set storedin a memory 154.

FIG. 61 illustrates an operational flow 6100 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 61 illustrates an example embodiment where the example operationalflow 6000 of FIG. 60 may include at least one additional operation.Additional operations may include an operation 6110.

After a start operation, an operation 6010, an operation 6020, and anoperation 6030, the operational flow 6100 moves to an operation 6110.Operation 6110 illustrates recording the detected medical conditionparameter data. It will be appreciated that a sleep state may beincluded as a medical condition. For example, as shown in FIGS. 1Athrough 1H, the detected medical condition data may be recorded to thememory 154.

FIG. 62 illustrates an operational flow 6200 representing exampleoperations related to maintaining a hands-free article for dispensing aninhalable compound according to a dosing instruction set, where thehands-free article is maintained in an operable dispensing position.FIG. 62 illustrates an example embodiment where the example operationalflow 6000 of FIG. 60 may include at least one additional operation.Additional operations may include an operation 6210, an operation 6212,and/or an operation 6214.

After a start operation, an operation 6010, an operation 6020, and anoperation 6030, the operational flow 6200 moves to an operation 6210.Operation 6210 illustrates transferring the detected medical conditionparameter data. For example, as shown in FIGS. 1A through 1H, thedetected medical condition data stored in the memory 154 may betransferred to a flash drive 64.

The operation 6212 illustrates transferring the detected medicalcondition parameter data to a flash drive. For example, as shown inFIGS. 1A through 1H, the detected medical condition data stored in thememory 154 may be transferred to a flash drive 64.

The operation 6214 illustrates transferring the detected medicalcondition parameter data to a hard drive. For example, as shown in FIGS.1A through 1H, the detected medical condition data stored in the memory154 may be transferred to a hard drive 66.

FIG. 63 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 63 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6302.

The operation 6302 illustrates downloading the detected medicalcondition parameter data to a RAM. For example, as shown in FIGS. 1Athrough 1H, the detected medical condition data stored in the memory 154may be downloaded to a random access memory (RAM) 68. In an embodiment,the detected medical condition data may be transmitted to a processor(e.g., processor 156). In an embodiment, the detected medical conditionmay be transmitted to an external site (e.g., the medical response unit192).

FIG. 64 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 64 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6402, and/or an operation 6404.

The operation 6402 illustrates transmitting the detected medicalcondition parameter to a dispensing module. For example, as shown inFIGS. 1A through 1H, the detected medical condition data stored in thememory 154 may be transmitted to the dispensing module 128. Further, theoperation 6404 illustrates transmitting the detected medical conditionparameter to a dispensing module via a wireless transmission. Forexample, as shown in FIGS. 1A through 1H, the detected medical conditiondata stored in the memory 154 may be transmitted to the dispensingmodule 128 wirelessly.

FIG. 65 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 65 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6502. Further, the operation 6502illustrates transmitting the detected medical condition parameter to adispensing module via a wire transmission. For example, as shown inFIGS. 1A through 1H, the detected medical condition data stored in thememory 154 may be transmitted to the dispensing module 128 via a wiredconnection.

FIG. 66 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 66 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6602. Further, the operation 6602illustrates transmitting the detected medical condition parameter to adispensing module via a radio transmission. For example, as shown inFIGS. 1A through 1H, the detected medical condition data stored in thememory 154 may be transmitted to the dispensing module 128 via a radiosignal.

FIG. 67 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 67 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6702. Further, the operation 6702illustrates transmitting the detected medical condition parameter to adispensing module via an optical transmission. For example, as shown inFIGS. 1A through 1H, the detected medical condition data stored in thememory 154 may be transmitted to the dispensing module 128 via anoptical transmission.

FIG. 68 illustrates alternative embodiments of the example operationalflow 6200 of FIG. 62. FIG. 68 illustrates example embodiments where theoperation 6210 may include at least one additional operation. Additionaloperations may include an operation 6802. Further, the operation 6802illustrates transmitting the detected medical condition parameter to adispensing module via a mechanical transmission. For example, as shownin FIGS. 1A through 1H, the detected medical condition data stored inthe memory 154 may be transmitted to the dispensing module 128 via amechanical transmission.

In an embodiment, the collar 100 may include a metered dose inhaler fordelivering a metered dosage of an inhaled bronchodilator when the sensormodule 170 detects a condition (e.g., an asthmatic incident includingnarrowing of the subject's airways) or a symptom indicative of acondition (e.g., narrowing of the subject's airways, wheezing, ordecreased exhalation volume). In an embodiment, the sensor module 170transmits the detected condition or symptom to the processor 156. Theprocessor 156 utilizes information stored in the memory 154 to determinethe most appropriate course of action for the detectedcondition/symptom. For example, the memory 154 may include instructionsfor dispensing (e.g., via the dispensing module 128) a metered dose ofthe inhaled bronchodilator (which is stored in reservoir 180) when theincident is detected. In an embodiment, the memory 154 includesinstructions for subsequent administration of the bronchodilator at sometime after the initial condition/symptom is detected (e.g., in the caseof a late-phase allergic reaction). The memory 154 may also includeinstructions for activating a visual indicator 196 so that the subject102 or an observer may be alerted to the subject's condition.

Those having skill in the art will recognize that the state of the arthas progressed to the point where there is little distinction leftbetween hardware, software, and/or firmware implementations of aspectsof systems; the use of hardware, software, and/or firmware is generally(but not always, in that in certain contexts the choice between hardwareand software can become significant) a design choice representing costvs. efficiency tradeoffs. Those having skill in the art will appreciatethat there are various vehicles by which processes and/or systems and/orother technologies described herein can be effected (e.g., hardware,software, and/or firmware), and that the preferred vehicle will varywith the context in which the processes and/or systems and/or othertechnologies are deployed. For example, if an implementer determinesthat speed and accuracy are paramount, the implementer may opt for amainly hardware and/or firmware vehicle; alternatively, if flexibilityis paramount, the implementer may opt for a mainly softwareimplementation; or, yet again alternatively, the implementer may opt forsome combination of hardware, software, and/or firmware. Hence, thereare several possible vehicles by which the processes and/or devicesand/or other technologies described herein may be effected, none ofwhich is inherently superior to the other in that any vehicle to beutilized is a choice dependent upon the context in which the vehiclewill be deployed and the specific concerns (e.g., speed, flexibility, orpredictability) of the implementer, any of which may vary. Those skilledin the art will recognize that optical aspects of implementations willtypically employ optically-oriented hardware, software, and or firmware.

In some implementations described herein, Logic and similarimplementations may include software or other control structures.Electronic circuitry, for example, may have one or more paths ofelectrical current constructed and arranged to implement variousfunctions as described herein. In some implementations, one or moremedia may be configured to bear a device-detectable implementation whensuch media hold or transmit device detectable instructions operable toperform as described herein. In some variants, for example,implementations may include an update or modification of existingsoftware or firmware, or of gate arrays or programmable hardware, suchas by performing a reception of or a transmission of one or moreinstructions in relation to one or more operations described herein.Alternatively or additionally, in some variants, an implementation mayinclude special-purpose hardware, software, firmware components, and/orgeneral-purpose components executing or otherwise invokingspecial-purpose components. Specifications or other implementations maybe transmitted by one or more instances of tangible transmission mediaas described herein, optionally by packet transmission or otherwise bypassing through distributed media at various times.

Alternatively or additionally, implementations may include executing aspecial-purpose instruction sequence or invoking circuitry for enabling,triggering, coordinating, requesting, or otherwise causing one or moreoccurrences of virtually any functional operations described herein. Insome variants, operational or other logical descriptions herein may beexpressed as source code and compiled or otherwise invoked as anexecutable instruction sequence. In some contexts, for example,implementations may be provided, in whole or in part, by source code,such as C++, or other code sequences. In other implementations, sourceor other code implementation, using commercially available and/ortechniques in the art, may be compiled/implemented/translated/convertedinto a high-level descriptor language (e.g., initially implementingdescribed technologies in C or C++ programming language and thereafterconverting the programming language implementation into alogic-synthesizable language implementation, a hardware descriptionlanguage implementation, a hardware design simulation implementation,and/or other such similar mode(s) of expression). For example, some orall of a logical expression (e.g., computer programming languageimplementation) may be manifested as a Verilog-type hardware description(e.g., via Hardware Description Language (HDL) and/or Very High SpeedIntegrated Circuit Hardware Descriptor Language (VHDL)) or othercircuitry model which may then be used to create a physicalimplementation having hardware (e.g., an Application Specific IntegratedCircuit). Those skilled in the art will recognize how to obtain,configure, and optimize suitable transmission or computational elements,material supplies, actuators, or other structures in light of theseteachings.

The foregoing detailed description has set forth various embodiments ofthe devices and/or processes via the use of block diagrams, flowcharts,and/or examples. Insofar as such block diagrams, flowcharts, and/orexamples contain one or more functions and/or operations, it will beunderstood by those within the art that each function and/or operationwithin such block diagrams, flowcharts, or examples can be implemented,individually and/or collectively, by a wide range of hardware, software,firmware, or virtually any combination thereof. In one embodiment,several portions of the subject matter described herein may beimplemented via Application Specific Integrated Circuits (ASICs), FieldProgrammable Gate Arrays (FPGAs), digital signal processors (DSPs), orother integrated formats. However, those skilled in the art willrecognize that some aspects of the embodiments disclosed herein, inwhole or in part, can be equivalently implemented in integratedcircuits, as one or more computer programs running on one or morecomputers (e.g., as one or more programs running on one or more computersystems), as one or more programs running on one or more processors(e.g., as one or more programs running on one or more microprocessors),as firmware, or as virtually any combination thereof, and that designingthe circuitry and/or writing the code for the software and or firmwarewould be well within the skill of one of skill in the art in light ofthis disclosure. In addition, those skilled in the art will appreciatethat the mechanisms of the subject matter described herein are capableof being distributed as a program product in a variety of forms, andthat an illustrative embodiment of the subject matter described hereinapplies regardless of the particular type of signal bearing medium usedto actually carry out the distribution. Examples of a signal bearingmedium include, but are not limited to, the following: a recordable typemedium such as a floppy disk, a hard disk drive, a Compact Disc (CD), aDigital Video Disk (DVD), a digital tape, a computer memory, etc.; and atransmission type medium such as a digital and/or an analogcommunication medium (e.g., a fiber optic cable, a waveguide, a wiredcommunications link, a wireless communication link (e.g., transmitter,receiver, transmission logic, reception logic, etc.), etc.).

In a general sense, those skilled in the art will recognize that thevarious embodiments described herein can be implemented, individuallyand/or collectively, by various types of electro-mechanical systemshaving a wide range of electrical components such as hardware, software,firmware, and/or virtually any combination thereof; and a wide range ofcomponents that may impart mechanical force or motion such as rigidbodies, spring or torsional bodies, hydraulics, electro-magneticallyactuated devices, and/or virtually any combination thereof.Consequently, as used herein “electro-mechanical system” includes, butis not limited to, electrical circuitry operably coupled with atransducer (e.g., an actuator, a motor, a piezoelectric crystal, a MicroElectro Mechanical System (MEMS), etc.), electrical circuitry having atleast one discrete electrical circuit, electrical circuitry having atleast one integrated circuit, electrical circuitry having at least oneapplication specific integrated circuit, electrical circuitry forming ageneral purpose computing device configured by a computer program (e.g.,a general purpose computer configured by a computer program which atleast partially carries out processes and/or devices described herein,or a microprocessor configured by a computer program which at leastpartially carries out processes and/or devices described herein),electrical circuitry forming a memory device (e.g., forms of memory(e.g., random access, flash, read only, etc.)), electrical circuitryforming a communications device (e.g., a modem, communications switch,optical-electrical equipment, etc.), and/or any non-electrical analogthereto, such as optical or other analogs. Those skilled in the art willalso appreciate that examples of electro-mechanical systems include butare not limited to a variety of consumer electronics systems, medicaldevices, as well as other systems such as motorized transport systems,factory automation systems, security systems, and/orcommunication/computing systems. Those skilled in the art will recognizethat electro-mechanical as used herein is not necessarily limited to asystem that has both electrical and mechanical actuation except ascontext may dictate otherwise.

In a general sense, those skilled in the art will recognize that thevarious aspects described herein which can be implemented, individuallyand/or collectively, by a wide range of hardware, software, firmware,and/or any combination thereof can be viewed as being composed ofvarious types of “electrical circuitry.” Consequently, as used herein“electrical circuitry” includes, but is not limited to, electricalcircuitry having at least one discrete electrical circuit, electricalcircuitry having at least one integrated circuit, electrical circuitryhaving at least one application specific integrated circuit, electricalcircuitry forming a general purpose computing device configured by acomputer program (e.g., a general purpose computer configured by acomputer program which at least partially carries out processes and/ordevices described herein, or a microprocessor configured by a computerprogram which at least partially carries out processes and/or devicesdescribed herein), electrical circuitry forming a memory device (e.g.,forms of memory (e.g., random access, flash, read only, etc.)), and/orelectrical circuitry forming a communications device (e.g., a modem,communications switch, optical-electrical equipment, etc.). Those havingskill in the art will recognize that the subject matter described hereinmay be implemented in an analog or digital fashion or some combinationthereof.

Those skilled in the art wilt recognize that at least a portion of thedevices and/or processes described herein can be integrated into a dataprocessing system. Those having skill in the art wilt recognize that adata processing system generally includes one or more of a system unithousing, a video display device, memory such as volatile or non-volatilememory, processors such as microprocessors or digital signal processors,computational entities such as operating systems, drivers, graphicaluser interfaces, and applications programs, one or more interactiondevices (e.g., a touch pad, a touch screen, an antenna, etc.), and/orcontrol systems including feedback Loops and control motors (e.g.,feedback for sensing position and/or velocity; control motors for movingand/or adjusting components and/or quantities). A data processing systemmay be implemented utilizing suitable commercially available components,such as those typically found in data computing/communication and/ornetwork computing/communication systems.

All of the above U.S. patents, U.S. patent application publications,U.S. patent applications, foreign patents, foreign patent applicationsand non-patent publications referred to in this specification and/orlisted in any Application Data Sheet, are incorporated herein byreference, to the extent not inconsistent herewith.

One skilled in the art will recognize that the herein describedcomponents (e.g., operations), devices, objects, and the discussionaccompanying them are used as examples for the sake of conceptualclarity and that various configuration modifications are contemplated.Consequently, as used herein, the specific exemplars set forth and theaccompanying discussion are intended to be representative of their moregeneral classes. In general, use of any specific exemplar is intended tobe representative of its class, and the non-inclusion of specificcomponents (e.g., operations), devices, and objects should not be takenlimiting.

Although user 166 is shown/described herein as a single illustratedfigure, those skilled in the art will appreciate that user 166 may berepresentative of a human user, a robotic user (e.g., computationalentity), and/or substantially any combination thereof (e.g., a user maybe assisted by one or more robotic agents) unless context dictatesotherwise. Those skilled in the art will appreciate that, in general,the same may be said of “sender” and/or other entity-oriented terms assuch terms are used herein unless context dictates otherwise.

With respect to the use of substantially any plural and/or singularterms herein, those having skill in the art can translate from theplural to the singular and/or from the singular to the plural as isappropriate to the context and/or application. The varioussingular/plural permutations are not expressly set forth herein for sakeof clarity.

The herein described subject matter sometimes illustrates differentcomponents contained within, or connected with, different othercomponents. It is to be understood that such depicted architectures aremerely exemplary, and that in fact many other architectures may beimplemented which achieve the same functionality. In a conceptual sense,any arrangement of components to achieve the same functionality iseffectively “associated” such that the desired functionality isachieved. Hence, any two components herein combined to achieve aparticular functionality can be seen as “associated with” each othersuch that the desired functionality is achieved, irrespective ofarchitectures or intermedial components. Likewise, any two components soassociated can also be viewed as being “operably connected”, or“operably coupled,” to each other to achieve the desired functionality,and any two components capable of being so associated can also be viewedas being “operably couplable,” to each other to achieve the desiredfunctionality. Specific examples of operably couplable include but arenot limited to physically mateable and/or physically interactingcomponents, and/or wirelessly interactable, and/or wirelesslyinteracting components, and/or logically interacting, and/or logicallyinteractable components.

In some instances, one or more components may be referred to herein as“configured to,” “configurable to,” “operable/operative to,”“adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Thoseskilled in the art will recognize that such terms (e.g. “configured to”)can generally encompass active-state components and/or inactive-statecomponents and/or standby-state components, unless context requiresotherwise.

While particular aspects of the present subject matter described hereinhave been shown and described, it will be apparent to those skilled inthe art that, based upon the teachings herein, changes and modificationsmay be made without departing from the subject matter described hereinand its broader aspects and, therefore, the appended claims are toencompass within their scope all such changes and modifications as arewithin the true spirit and scope of the subject matter described herein.It will be understood by those within the art that, in general, termsused herein, and especially in the appended claims (e.g., bodies of theappended claims) are generally intended as “open” terms (e.g., the term“including” should be interpreted as “including but not limited to,” theterm “having” should be interpreted as “having at least,” the term“includes” should be interpreted as “includes but is not limited to,”etc.). It will be further understood by those within the art that if aspecific number of an introduced claim recitation is intended, such anintent wilt be explicitly recited in the claim, and in the absence ofsuch recitation no such intent is present. For example, as an aid tounderstanding, the following appended claims may contain usage of theintroductory phrases “at least one” and “one or more” to introduce claimrecitations. However, the use of such phrases should not be construed toimply that the introduction of a claim recitation by the indefinitearticles “a” or “an” limits any particular claim containing suchintroduced claim recitation to claims containing only one suchrecitation, even when the same claim includes the introductory phrases“one or more” or “at least one” and indefinite articles such as “a” or“an” (e.g., “a” and/or “an” should typically be interpreted to mean “atleast one” or “one or more”); the same holds true for the use ofdefinite articles used to introduce claim recitations. In addition, evenif a specific number of an introduced claim recitation is explicitlyrecited, those skilled in the art will recognize that such recitationshould typically be interpreted to mean at least the recited number(e.g., the bare recitation of “two recitations,” without othermodifiers, typically means at least two recitations, or two or morerecitations). Furthermore, in those instances where a conventionanalogous to “at least one of A, B, and C, etc.” is used, in generalsuch a construction is intended in the sense one having skill in the artwould understand the convention (e.g., “a system having at least one ofA, B, and C” would include but not be limited to systems that have Aalone, B alone, C alone, A and B together, A and C together, B and Ctogether, and/or A, B, and C together, etc.). In those instances where aconvention analogous to “at least one of A, B, or C, etc.” is used, ingeneral such a construction is intended in the sense one having skill inthe art would understand the convention (e.g., “a system having at leastone of A, B, or C” would include but not be limited to systems that haveA alone, B alone, C alone, A and B together, A and C together, B and Ctogether, and/or A, B, and C together, etc.). It wilt be furtherunderstood by those within the art that typically a disjunctive wordand/or phrase presenting two or more alternative terms, whether in thedescription, claims, or drawings, should be understood to contemplatethe possibilities of including one of the terms, either of the terms, orboth terms unless context dictates otherwise. For example, the phrase “Aor B” will be typically understood to include the possibilities of “A”or “B” or “A and B.”

With respect to the appended claims, those skilled in the art willappreciate that recited operations therein may generally be performed inany order. Also, although various operational flows are presented in asequence(s), it should be understood that the various operations may beperformed in other orders than those which are illustrated, or may beperformed concurrently. Examples of such alternate orderings may includeoverlapping, interleaved, interrupted, reordered, incremental,preparatory, supplemental, simultaneous, reverse, or other variantorderings, unless context dictates otherwise. Furthermore, terms like“responsive to,” “related to,” or other past-tense adjectives aregenerally not intended to exclude such variants, unless context dictatesotherwise.

1. A method for administering an inhalable compound, comprising:dispensing for inhalation by a user a dose of an inhalable compoundaccording to a dosing instruction set; and maintaining in physicalassociation with the user a hands-free article for dispensing theinhalable compound in an operable dispensing position.
 2. The method ofclaim 1, wherein the user is at least one of a human, an animal, amammal, and a pet.
 3. The method of claim 1, wherein dispensing forinhalation by a user a dose of an inhalable compound according to adosing instruction set comprises: dispensing a dose of an inhalablecompound according to a defined dosing instruction set.
 4. The method ofclaim 3, wherein dispensing a dose of an inhalable compound according toa defined dosing instruction set comprises: dispensing a dose of aninhalable compound according to a time defined dosing instruction set.5. The method of claim 3, wherein dispensing a dose of an inhalablecompound according to a defined dosing instruction set comprises:dispensing a dose of an inhalable compound according to a user defineddosing instruction set.
 6. The method of claim 3, wherein dispensing adose of an inhalable compound according to a defined dosing instructionset comprises: dispensing a dose of an inhalable compound according to ahealth care provider-defined dosing instruction set.
 7. The method ofclaim 3, wherein dispensing a dose of an inhalable compound according toa defined dosing instruction set comprises: dispensing a dose of aninhalable compound according to a need response dosing instruction set.8. The method of claim 3, wherein dispensing a dose of an inhalablecompound according to a defined dosing instruction set comprises:dispensing a dose of an inhalable compound according to a environmentalneed response dosing instruction set.
 9. The method of claim 3, whereindispensing a dose of an inhalable compound according to a defined dosinginstruction set comprises: dispensing a dose of an inhalable compoundaccording to a location need response dosing instruction set.
 10. Themethod of claim 3, wherein dispensing a dose of an inhalable compoundaccording to a defined dosing instruction set comprises: dispensing adose of an inhalable compound according to a proximate presence orabsence of other living beings.
 11. The method of claim 1, whereindispensing for inhalation by a user a dose of an inhalable compoundaccording to a dosing instruction set comprises: dispensing a dose of apharmaceutical compound.
 12. The method of claim 1, wherein dispensingfor inhalation by a user a dose of an inhalable compound according to adosing instruction set comprises: dispensing a dose of a nutraceuticalcompound.
 13. The method of claim 1, wherein dispensing for inhalationby a user a dose of an inhalable compound according to a dosinginstruction set comprises: dispensing a dose of a therapeutic compound.14. The method of claim 1, wherein dispensing for inhalation by a user adose of an inhalable compound according to a dosing instruction setcomprises: dispensing a dose of a homeopathic compound.
 15. The methodof claim 1, further comprising: directing issuance of a dispensingorder.
 16. The method of claim 3, further comprising: accepting a dosinginstruction set from a user.
 17. The method of claim 3, furthercomprising: accepting a dosing instruction set from at least one of aphysician, a health care provider, a physician's assistant, a nurse, anurse practitioner, a registered nurse, a licensed practical nurse, apharmacist, or an emergency responder.
 18. The method of claim 3,further comprising: accepting a dosing instruction set from a medicalresponse unit.
 19. The method of claim 3, further comprising: validatinga dosing instruction set for performing a function.
 20. The method ofclaim 3, further comprising: translating a dosing instruction set forperforming a function into a dispensing order.
 21. The method of claim3, further comprising: translating a medical parameter into a dispensingorder.
 22. The method of claim 3, further comprising: generating adispensing order according to the instruction set from a user.
 23. Themethod of claim 3, further comprising: generating a dispensing orderaccording to the instruction set from a health care professional. 24.The method of claim 3, further comprising: generating a dispensing orderaccording to the instruction set from a medical response unit.
 25. Themethod of claim 1, further comprising: transmitting a dispensing orderto a dispensing module.
 26. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a wirelesstransmission.
 27. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a opticaltransmission.
 28. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a wiretransmission.
 29. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a mechanicaltransmission.
 30. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a radiotransmission.
 31. The method of claim 1, further comprising:transmitting a dispensing order to a dispensing module via a processortransmission.
 32. The method of claim 3, wherein dispensing a dose of aninhalable compound according to a defined dosing instruction setcomprises: dispensing the inhalable compound in accordance with adispensing order received by a dispensing module.
 33. The method ofclaim 3, further comprising: requesting a dose of the inhalable compoundin accordance with a dispensing order received by a dispensing modulefrom a reservoir.
 34. The method of claim 1, wherein dispensing forinhalation by a user a dose of an inhalable compound according to adosing instruction set comprises: generating an aerosol of the inhalablecompound.
 35. The method of claim 1, wherein dispensing for inhalationby a user a dose of an inhalable compound according to a dosinginstruction set comprises: generating at least one of a vapor or apowder of the inhalable compound.
 36. The method of claim 1, whereindispensing for inhalation by a user a dose of an inhalable compoundaccording to a dosing instruction set comprises: generating a liquidatomization of the inhalable compound.
 37. The method of claim 1,wherein dispensing for inhalation by a user a dose of an inhalablecompound according to a dosing instruction set comprises: administeringthe inhalable compound via spraying a compound.
 38. The method of claim1, wherein dispensing for inhalation by a user a dose of an inhalablecompound according to a dosing instruction set comprises: administeringthe inhalable compound via at least one of dusting or powderizing acompound.
 39. The method of claim 1, wherein dispensing for inhalationby a user a dose of an inhalable compound according to a dosinginstruction set comprises: administering the inhalable compound vianebulizing a compound.
 40. The method of claim 1, wherein dispensing forinhalation by a user a dose of an inhalable compound according to adosing instruction set comprises: administering the inhalable compoundvia vaporizing a compound.
 41. The method of claim 1, wherein dispensingfor inhalation by a user a dose of an inhalable compound according to adosing instruction set comprises: administering an inhalable compoundincluding a carrier.
 42. The method of claim 1, further comprising:controlling delivery of the inhalable compound.
 43. The method of claim42, wherein controlling delivery of the inhalable compound comprises:selecting one or more delivery nozzles from a suite of nozzles.
 44. Themethod of claim 42, wherein controlling delivery of the inhalablecompound comprises: directing delivery of the inhalable compound fromone or more nozzles at different locations.
 45. The method of claim 42,wherein controlling delivery of the inhalable compound comprises:directing delivery of the inhalable compound by controlling a dischargedirection.
 46. The method of claim 42, wherein controlling delivery ofthe inhalable compound comprises: directing delivery via a demand valvecoupled with programmable dosing.
 47. The method of claim 42, whereincontrolling delivery of the inhalable compound comprises: directingdelivery via a charged particle dispersion.
 48. The method of claim 42,wherein controlling delivery of the inhalable compound comprises:directing delivery via a nozzle comprising variable dischargecharacteristics.
 49. The method of claim 1, wherein maintaining inphysical association with the user a hands-free article for dispensingthe inhalable compound in an operable dispensing position comprises:orienting a dispensing module to optimize respiratory receipt of aninhalable compound.
 50. The method of claim 1, wherein maintaining inphysical association with the user a hands-free article for dispensingthe inhalable compound in an operable dispensing position comprises:maintaining a dispensing module in position to optimize respiratoryreceipt of an inhalable compound.
 51. The method of claim 1, whereinmaintaining in physical association with the user a hands-free articlefor dispensing the inhalable compound in an operable dispensing positioncomprises: determining a relative position or direction to a desiredrespiratory target.
 52. The method of claim 1, wherein maintaining inphysical association with the user a hands-free article for dispensingthe inhalable compound in an operable dispensing position comprises:maintaining a position of the dispensing module via a weight.
 53. Themethod of claim 1, wherein maintaining in physical association with theuser a hands-free article for dispensing the inhalable compound in anoperable dispensing position comprises: maintaining a position of thedispensing module via an adhesive.
 54. The method of claim 1, whereinmaintaining in physical association with the user a hands-free articlefor dispensing the inhalable compound in an operable dispensing positioncomprises: maintaining a position of the dispensing module via a slide.55. The method of claim 1, wherein maintaining in physical associationwith the user a hands-free article for dispensing the inhalable compoundin an operable dispensing position comprises: maintaining a position ofthe dispensing module via a magnet.
 56. The method of claim 1, whereinmaintaining in physical association with the user a hands-free articlefor dispensing the inhalable compound in an operable dispensing positioncomprises: maintaining a position of the dispensing module via afastener.
 57. The method of claim 1, wherein maintaining in physicalassociation with the user a hands-free article for dispensing theinhalable compound in an operable dispensing position comprises:maintaining a position of the dispensing module via a spring.
 58. Themethod of claim 1, further comprising: dispensing a tracer compound inassociation with the inhalable compound.
 59. The method of claim 58,wherein dispensing a tracer compound in association with the inhalablecompound comprises: dispensing a visual tracer compound.
 60. The methodof claim 58, wherein dispensing a tracer compound in association withthe inhalable compound comprises: dispensing an olfactory tracercompound.
 61. The method of claim 58, wherein dispensing a tracercompound in association with the inhalable compound comprises:dispensing a tastable tracer compound.
 62. The method of claim 1,further comprising: providing an externally observable indication ofdispensing of the inhalable compound.
 63. The method of claim 62,wherein providing an externally observable indication of dispensing ofthe inhalable compound comprises: providing a visual indication ofdispensing of the inhalable compound.
 64. The method of claim 62,wherein providing an externally observable indication of dispensing ofthe inhalable compound comprises: providing a auditory indication ofdispensing of the inhalable compound.
 65. The method of claim 62,wherein providing an externally observable indication of dispensing ofthe inhalable compound comprises: providing a vibrational indication ofdispensing of the inhalable compound.
 66. The method of claim 62,wherein providing an externally observable indication of dispensing ofthe inhalable compound comprises: providing a electromagnetic indicationof dispensing of the inhalable compound.